News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
299,989 Results
Type
Article (21787)
Company Profile (22)
Press Release (278180)
Section
Business (76571)
Career Advice (796)
Deals (12766)
Drug Delivery (53)
Drug Development (49882)
Employer Resources (67)
FDA (8444)
Job Trends (6662)
News (148392)
Policy (14947)
Tag
2024 BioMidwest Digital (1)
2024 Biotech Bay Standard (3)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (2)
2024 Pharm Country Standard (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
Academia (1761)
Adcomms (15)
Allergies (40)
Alliances (17487)
ALS (50)
Alzheimer's disease (963)
Antibody-drug conjugate (ADC) (38)
Approvals (8457)
Artificial intelligence (76)
Autoimmune disease (6)
Automation (8)
Bankruptcy (134)
Best Places to Work (5944)
BIOSECURE Act (10)
Biosimilars (18)
Biotechnology (18)
Bladder cancer (38)
Brain cancer (16)
Breast cancer (128)
Cancer (1019)
Cardiovascular disease (109)
Career advice (667)
Career pathing (14)
CAR-T (69)
Cell therapy (194)
Cervical cancer (9)
Clinical research (40468)
Collaboration (277)
Compensation (107)
Complete response letters (9)
COVID-19 (1256)
CRISPR (21)
C-suite (52)
Cystic fibrosis (55)
Data (1203)
Decentralized trials (2)
Denatured (1)
Depression (16)
Diabetes (145)
Diagnostics (3029)
Digital health (6)
Diversity (2)
Diversity, equity & inclusion (25)
Drug discovery (54)
Drug pricing (59)
Drug shortages (18)
Duchenne muscular dystrophy (35)
Earnings (33095)
Editorial (13)
Employer branding (4)
Employer resources (59)
Events (45645)
Executive appointments (215)
FDA (9012)
Featured Employer (11)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (270)
Gene editing (56)
Generative AI (6)
Gene therapy (181)
GLP-1 (391)
Government (2576)
Grass and pollen (2)
Guidances (22)
Healthcare (9888)
Huntington's disease (9)
IgA nephropathy (14)
Immunology and inflammation (31)
Indications (15)
Infectious disease (1324)
Inflammatory bowel disease (60)
Inflation Reduction Act (4)
Influenza (23)
Intellectual property (35)
Interviews (98)
IPO (6721)
IRA (21)
Job creations (969)
Job search strategy (615)
Kidney cancer (9)
Labor market (7)
Layoffs (139)
Leadership (7)
Legal (2551)
Liver cancer (36)
Lung cancer (148)
Lymphoma (77)
Machine learning (1)
Management (24)
Manufacturing (83)
MASH (61)
Medical device (6234)
Medtech (6236)
Mergers & acquisitions (6205)
Metabolic disorders (369)
Multiple sclerosis (30)
NASH (19)
Neurodegenerative disease (41)
Neuropsychiatric disorders (9)
Neuroscience (1208)
NextGen: Class of 2025 (3108)
Non-profit (2854)
Northern California (1130)
Now hiring (27)
Obesity (180)
Opinion (96)
Ovarian cancer (33)
Pain (54)
Pancreatic cancer (52)
Parkinson's disease (66)
Partnered (6)
Patents (78)
Patient recruitment (54)
Peanut (22)
People (22089)
Pharmaceutical (10)
Pharmacy benefit managers (10)
Phase I (11783)
Phase II (17938)
Phase III (13716)
Pipeline (478)
Podcasts (18)
Policy (55)
Postmarket research (1886)
Preclinical (5354)
Press Release (18)
Prostate cancer (48)
Psychedelics (10)
Radiopharmaceuticals (122)
Rare diseases (201)
Real estate (1531)
Recruiting (21)
Regulatory (10846)
Reports (11)
Research institute (1276)
Resumes & cover letters (114)
Rett syndrome (2)
RSV (18)
Schizophrenia (36)
Series A (35)
Series B (23)
Service/supplier (1)
Sickle cell disease (34)
Southern California (949)
Special edition (4)
Sponsored (11)
Startups (1240)
Stomach cancer (2)
Supply chain (23)
The Weekly (17)
United States (9435)
Vaccines (264)
Venture capitalists (8)
Webinars (5)
Weight loss (112)
Women's health (11)
Worklife (3)
Date
Today (74)
Last 7 days (401)
Last 30 days (1451)
Last 365 days (17502)
2025 (2683)
2024 (17882)
2023 (20240)
2022 (24560)
2021 (26535)
2020 (25470)
2019 (22603)
2018 (17042)
2017 (14773)
2016 (13953)
2015 (16716)
2014 (11977)
2013 (9441)
2012 (10270)
2011 (10774)
2010 (9905)
Location
Africa (290)
Alabama (27)
Alaska (3)
Arizona (58)
Arkansas (6)
Asia (15118)
Australia (2986)
California (2451)
Canada (837)
China (193)
Colorado (102)
Connecticut (120)
Delaware (53)
Europe (37048)
Florida (366)
Georgia (93)
Idaho (21)
Illinois (236)
India (8)
Indiana (139)
Iowa (2)
Japan (68)
Kansas (67)
Kentucky (11)
Louisiana (5)
Maine (29)
Maryland (389)
Massachusetts (1652)
Michigan (82)
Minnesota (137)
Mississippi (1)
Missouri (36)
Montana (15)
Nebraska (12)
Nevada (29)
New Hampshire (31)
New Jersey (826)
New Mexico (6)
New York (757)
North Carolina (437)
North Dakota (4)
Northern California (1130)
Ohio (98)
Oklahoma (2)
Oregon (16)
Pennsylvania (547)
Puerto Rico (4)
Rhode Island (3)
South America (492)
South Carolina (10)
South Dakota (1)
Southern California (949)
Tennessee (49)
Texas (338)
Utah (76)
Virginia (66)
Washington D.C. (34)
Washington State (271)
West Virginia (1)
Wisconsin (14)
299,989 Results for "american stroke association".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Approvals
Roche Continues Regulatory Run With Acute Stroke Expansion for Heart Attack Drug
TNKase is the first stroke drug to win FDA approval in nearly three decades.
March 4, 2025
·
2 min read
·
Tristan Manalac
Press Releases
The American Diabetes Association and Lilly Collaborate on New Resources for Obesity Care
February 6, 2025
·
2 min read
Press Releases
The American Diabetes Association Announces 2025 Pathway to Stop Diabetes Grant Recipients
February 12, 2025
·
5 min read
Press Releases
Amarin Marks Key Milestone for VASCEPA®/VAZKEPA® (Icosapent Ethyl) -- Publication of Post Hoc Analysis of REDUCE-IT in Journal of the American Heart Association Reports Benefit on Top of Cholesterol Lowering
February 28, 2025
·
14 min read
Press Releases
International Stroke Conference 2025: Remedy Pharmaceuticals Unveils Landmark CIRARA® Data Demonstrating Significant Improvements in Stroke Outcomes
February 19, 2025
·
4 min read
Press Releases
DiaMedica Therapeutics Announces Publication of DM199’s Mechanism of Action for the Treatment of Acute Ischemic Stroke (AIS) in the Journal Stroke
February 20, 2025
·
7 min read
Press Releases
FDA Approves Genentech’s TNKase® in Acute Ischemic Stroke in Adults
March 3, 2025
·
9 min read
Press Releases
Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting
February 18, 2025
·
1 min read
Press Releases
Terumo Neuro Showcases Fully Integrated, Comprehensive Stroke Portfolio at International Stroke Conference Delivering Groundbreaking Innovation from Access to Revascularization
February 5, 2025
·
3 min read
Kiniksa Pharmaceuticals Sponsors American Heart Association’s Addressing Recurrent Pericarditis Initiative
Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (Kiniksa) today announced its sponsorship of the American Heart Association’s new Addressing Recurrent Pericarditis initiative, a multi-faceted effort to improve quality of care through identification, dissemination, and implementation of best practices for the diagnosis and management of recurrent pericarditis.
June 17, 2024
·
6 min read
1 of 29,999
Next
